OPTIMAL CONTROL OF INTERFERON-?? AND TUMOR NECROSIS FACTOR-?? BY INTERLEUKIN-10 PRODUCED IN RESPONSE TO ONE HLA-DR MISMATCH DURING THE PRIMARY MIXED LYMPHOCYTE REACTION1
- 15 February 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (3) , 497-502
- https://doi.org/10.1097/00007890-199602150-00031
Abstract
Interleukin (IL)-10 is an immunosuppressive cytokine potentially involved in the control of the allogeneic response. Several studies failed to detect it in mixed lymphocyte reaction supernatants. However, experiments using IL-10-specific antibodies, revealing its inhibitory action on interferon(IFN)-γ and tumor necrosis factor (TNF)-α, provided indirect evidence that endogenous IL-10 was produced. The aim of the present work is to elucidate the role of IL-10 during mixed lymphocyte reaction and to investigate the influence of HLA-DR antigens on its production and on the regulatory loop involving TNF-α and IFN-γ. Using a highly sensitive ELISA, a significant (PP=0.02) and, to a lesser extent, TNF-α(147±56% vs. 112±20%, NS) in 1 compared with 2 DR MM pairs. We conclude that the 1 DR MM setting is associated with optimal IL-10 secretion and more efficient inhibition of IFN-γ and TNF-α compared with the 2 DR MM configuration. Although promoting enhanced IFN-γ and TNF-α release, introduction of an additional DR MM does not result in increased IL-10 production. These data indicating that the IL-10 regulatory feedback loop is more effective in 1 DR rather than complete DR incompatibility could have an impact on matching policies for planned transfusion.Keywords
This publication has 24 references indexed in Scilit:
- The Role of Innate Immunity in Graft-Versus-Host Disease and Complications following Allogeneic Stem Cell TransplantTransplantation and Cellular Therapy, 2009
- INHIBITORY EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN 10 ON DISEASE MANIFESTATIONS IN A P→F1 MODEL OF ACUTE GRAFT VERSUS HOST DISEASETransplantation, 1995
- IL-10 Inhibits Alloreactive Cytotoxic T Lymphocyte Generation in VivoCellular Immunology, 1994
- Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.The Journal of Experimental Medicine, 1994
- Suppression of the allogeneic response by human IL-10: A critical role for suppression of a synergy between IL-2 and TNF-αCytokine, 1994
- High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.The Journal of Experimental Medicine, 1994
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- Interleukin-10Annual Review of Immunology, 1993
- HEART ALLOGRAFTS IN MURINE SYSTEMSTransplantation, 1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991